Imaging data from the CONTENTed study suggest the type 2 inflammation that drives severe asthma may affect more than the airways.
|Articles|September 17, 2021
Pharmacy Clinical Pearl of the Day: Migraine Types
Author(s)Saro Arakelians, PharmD
Migraine headaches can be caused by triggers such as hormonal changes, drinks, stress, sensory stimuli, sleep changes, physical factors, weather changes, medications, foods, and food additives.
Advertisement
Clinical Pearl of the Day: Migraine Types
A migraine is a headache that can cause severe throbbing pain or a pulsing sensation, usually on one side of the head.
Explanation:
- Migraine can be caused by triggers such as hormonal changes, drinks (coffee), stress, sensory stimuli, sleep changes, physical factors, weather changes, medications, foods, and food additives.
- Risk factors for migraine include age, sex, family history, and hormonal changes.
- Treatments include pain relievers, triptans, Reyvow, Ubrelvy, CGRP antagonists, opioids, and anti-nausea medications.
- Migraine types may include migraine with aura, migraine without aura, migraine without head pain, hemiplegic migraine, retinal migraine, chronic migraine, ice pick headaches, cluster headaches, and cervicogenic headaches.
References:
Advertisement
Related to this article
Researchers found substantial overlap in autonomic symptoms, orthostatic tachycardia, and functional impairment between long COVID and POTS.
A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
Insulin efsitora alfa-gobe (Onswik; Eli Lilly and Company) is designed to deliver steady basal insulin levels over a full 7-day duration.
Vallerie McLaughlin, MD, explains why the ERS update strongly recommends sotatercept for patients with pulmonary arterial hypertension (PAH) who don't reach low-risk status on initial therapy.
Renal benefit appeared only in patients with albuminuria in a 75,455-person BMJ analysis, whereas sulfonylureas signaled faster decline without it.
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5